Ranking of Decreasing Margin Buying Positions in Japan

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Stock	Price	Change	Volume	Margin Ratio	Buy Positions(Shares)	Weekly Change	Market Cap	Liquidity
Axelspace 402A TSE Growth	640	-62 -8.8%	4,688,700	105,394.00	10,539,400	-739,300	42.5B	High
Medrx 4586 TSE Growth	108	-6 -5.3%	1,112,500	0.00	6,635,500	-727,100	6.41B	Slightly High
OncoTherapy Science 4564 TSE Growth	23	0 ー%	92,380,900	16.64	20,015,300	-694,300	8.66B	Mid
Def consulting 4833 TSE Growth	70	-5 -6.7%	1,942,700	0.00	12,322,600	-627,200	5.05B	High
BrightPath Biotherapeutics 4594 TSE Growth	72	-4 -5.3%	5,226,000	12.67	18,176,400	-625,500	9.49B	Slightly High
eole 2334 TSE Growth	369	-9 -2.4%	599,400	67,625.00	6,762,500	-451,800	14.3B	High
Softfront Holdings 2321 TSE Growth	317	-23 -6.8%	1,460,400	175.71	1,036,700	-384,300	16.5B	Slightly High
Modalis Therapeutics 4883 TSE Growth	58	0 ー%	653,400	0.00	9,867,600	-339,000	5.07B	Mid
Monstarlab 5255 TSE Growth	103	-7 -6.4%	998,000	0.00	5,348,900	-316,100	6.68B	High
Finatext Holdings 4419 TSE Growth	951	+17 +1.82%	477,100	0.00	1,744,700	-307,700	49.4B	High
FRUTA FRUTA 2586 TSE Growth	115	-3 -2.5%	946,300	4,237.56	10,593,900	-300,700	11.7B	High
COVER 5253 TSE Growth	1,610	-1 -0.1%	1,402,700	2.76	3,683,700	-277,600	106B	High
PowerX 485A TSE Growth	5,870	+70 +1.21%	1,790,800	233.84	1,613,500	-255,000	221B	High
ELEMENTS 5246 TSE Growth	608	-22 -3.5%	516,400	22.77	4,316,400	-217,800	16.5B	High
Ai ROBOTICS 247A TSE Growth	1,261	-59 -4.5%	551,500	24.57	6,721,100	-209,300	79.6B	High
MEDINET 2370 TSE Growth	30	0 ー%	2,340,400	0.00	12,078,900	-200,300	8B	Mid
D.Western Therapeutics Institute 4576 TSE Growth	99	-2 -2.0%	607,700	0.00	5,920,900	-199,400	5.37B	Slightly High
Kubota Pharma 4596 TSE Growth	103	-5 -4.6%	3,082,000	0.00	6,393,000	-159,500	11.9B	High
QPS 464A TSE Growth	2,503	-129 -4.9%	4,454,200	10.36	2,859,200	-142,900	121B	High
Globalway 3936 TSE Growth	128	-10 -7.3%	319,300	0.00	2,543,200	-136,600	4.68B	Slightly High

About:

Liquidity

Liquidity Grade

Liquidity	1-Year Average Number of Trades	Distribution
High	Over 1,000	13.9%
Slightly-High	400 to 1,000	18.5%
Mid	50 to 400	39.0%
Slightly-Low	10 to 50	17.6%
Low	Less than 10	11.0%

Labels